TrialHuman vaccines & immunotherapeutics2016

Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013-2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu®.

Yonggang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.